Page last updated: 2024-10-30

mesalamine and Acute Generalised Exanthematous Pustulosis

mesalamine has been researched along with Acute Generalised Exanthematous Pustulosis in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"Mesalamine was discontinued, and thepatient's skin eruption, renal function, liver functiontests, and leukocytosis subsequently improved."1.46First report of mesalamine (5-aminosalicylic acid) as the causative agent in a case of acute generalized exanthamous pustulosis. ( Hutchens, K; Park, K; Rocci, E; Winterfield, L, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rocci, E1
Park, K1
Hutchens, K1
Winterfield, L1

Other Studies

1 other study available for mesalamine and Acute Generalised Exanthematous Pustulosis

ArticleYear
First report of mesalamine (5-aminosalicylic acid) as the causative agent in a case of acute generalized exanthamous pustulosis.
    Dermatology online journal, 2017, Jan-15, Volume: 23, Issue:1

    Topics: Acute Generalized Exanthematous Pustulosis; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis,

2017